GLAXO Share Price Performance
PK₨368.67
25.56 (7.45%)
Price PK₨368.67
Share Pricen/a
GlaxoSmithKline Pakistan Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 26 Fair Values set on narratives written by author
GLAXO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Flawless balance sheet with solid track record and pays a dividend.
1 Risk
2 Rewards
GlaxoSmithKline Pakistan Limited Key Details
About GLAXO
- Founded
- 2001
- Employees
- 1606
- CEO
- WebsiteView website
GlaxoSmithKline Pakistan Limited, a biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan. It offers products in the anti-infective, dermatology, respiratory, immunology and inflammation, oncology, infectious diseases, HIV, and vaccines therapy areas. The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol, Shingrix, and Cutivate brands. It also exports its products. The company was founded in 2001 and is headquartered in Karachi, Pakistan. GlaxoSmithKline Pakistan Limited operates as a subsidiary of GSK plc.